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Recent studies show a key role of brain inﬂammation in epilepsy. However, the
mechanisms controlling brain immune response are only partly understood. In the
periphery, acetylcholine (ACh) release by the vagus nerve restrains inﬂammation
by inhibiting the activation of leukocytes. Recent reports suggested a similar
anti-inﬂammatory effect for ACh in the brain. Since brain cholinergic dysfunctions
are documented in epileptic animals, we explored changes in brain cholinergic gene
expression and associated immune response during pilocarpine-induced epileptogenesis.
Levels of acetylcholinesterase (AChE) and inﬂammatory markers were measured using
real-time RT-PCR, in-situ hybridization and immunostaining in wild type (WT) and
transgenic mice over-expressing the “synaptic” splice variant AChE-S (TgS). One month
following pilocarpine, mice were video-monitored for spontaneous seizures. To test
directly the effect of ACh on the brain’s innate immune response, cytokines expression
levels were measured in acute brain slices treated with cholinergic agents. We report
a robust up-regulation of AChE as early as 48h following pilocarpine-induced status
epilepticus (SE). AChE was expressed in hippocampal neurons, microglia, and endothelial
cells but rarely in astrocytes. TgS mice overexpressing AChE showed constitutive
increased microglial activation, elevated levels of pro-inﬂammatory cytokines 48h after
SE and accelerated epileptogenesis compared to their WT counterparts. Finally we show
a direct, muscarine-receptor dependant, nicotine-receptor independent anti-inﬂammatory
effect of ACh in brain slices maintained ex vivo. Our work demonstrates for the ﬁrst time,
that ACh directly suppresses brain innate immune response and that AChE up-regulation
after SE is associated with enhanced immune response, facilitating the epileptogenic
process. Our results highlight the cholinergic system as a potential new target for the
prevention of seizures and epilepsy.
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INTRODUCTION
Accumulating experimental evidence indicates that brain
immune response and inﬂammatory mediators decrease the
threshold for individual seizures and contributes to the process
of epileptogenesis (for review see: Vezzani and Granata, 2005;
Rijkersetal.,2009;Vezzanietal.,2011).Therefore, understanding
the mechanisms controlling the extent and durationof the brain’s
inﬂammatory response to status epilepticus (SE) and injury may
promote the understanding of epileptogenesis and highlight new
therapeutic targets for the prevention and treatment of epilepsy.
Peripheral inﬂammation is controlled, amongst others, by the
cholinergic anti-inﬂammatory pathwaywhich involves inhibition
of innate immune responses by ACh released from the vagus
nerve. This mechanism is dependent on the alpha7subunit of
the nicotinic acetylcholine receptor (α7nAChR), which inhibits
NF-kappaBnuclear translocation and suppresses cytokine release
by monocytes and macrophages (Tracey, 2002, 2009). Centrally
acting inhibitors of the ACh hydrolyzing enzyme, acetyl-
cholinesterase (AChE), were shown to enhance the peripheral
cholinergic anti-inﬂammatory pathway via central muscarinic
receptors (Pavlov et al., 2006, 2009). Recent reports point toward
a cholinergic anti-inﬂammatory mechanism also in the cen-
tral nervous system (CNS). In cultured microglia, ACh pre-
treatment inhibited lipopolysaccharide (LPS)-induced tumor
necrosis factor alpha (TNFα) release via α7nAChR (Shytle et al.,
2004). Accordingly, AChE inhibition reduced microglial produc-
tion of TNFα in a hypoxia model (Wang et al., 2010). AChE
inhibitors have also been shown to reduce glial activation and
inﬂammatory cytokine production in experimental autoimmune
encephalomyelitis (Nizri et al., 2008) and in a cerebral hypoper-
fusion model in the rat (Wang et al., 2010).
We recently reported cholinergic dysfunction and up-
regulationofAChE intemporal lobestructures ofSE-experienced
epileptic rats (Zimmerman et al., 2008). These results raised the
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hypothesis that transcriptionally controlled cholinergic imbal-
ance may have a role in brain immune response during epilep-
togenesis. We thus used the pilocarpine model of epilepsy to
study AChE expression and the role of consequent cholinergic
imbalance on brain immune response and epileptogenesis.
MATERIALS AND METHODS
All animal experiments were approved by the Committee for
Ethics in Animal experimentation of the Faculty of Health
Sciences, Ben-Gurion University of the Negev. Wild type (WT)
FVB/N (Harlan Laboratories, Jerusalem), and transgenic mice
over-expressing human AChE-S (TgS) (Beeri et al., 1995)w e r e
maintained on a 12h light/dark cycle and had access to food and
wateradlibitum.AllchemicalswerepurchasedfromSigmaunless
otherwise mentioned.
PILOCARPINE TREATMENT
The well-established pilocapine model for temporal lobe epilepsy
was induced (Cavalheiro et al., 1996; Shibley and Smith, 2002;
Chen et al., 2005). Pilocarpine (290–340mg/kg i.p.) was injected
to adult (8–16 weeks old, 26–34g BW) male mice 15min after
pre-treatment withmethyl-scopolamine (1.5mg/kgi.p.).Animals
were observed for 2h after pilocarpine injection, and seizures
were evaluatedaccording to a modiﬁed version ofthe Racine scale
(Racine, 1972; Borges et al., 2003). SE was deﬁned by continu-
ous seizure activity consisting of stages 3.5–5 seizures, ﬁve taken
as the onset. Forty minutes from onset, SE was interrupted by
injection of diazepam (4mg/kg i.p.). Control mice were treated
with the same protocol, except that saline was injected instead of
pilocarpine, followed, 1h later, by diazepam.
Epilepsy was diagnosed in the presence of at least one spon-
taneous stage ﬁve seizure observed during a 48h period of
video-monitoring, 1–3 months after SE (in 11WT mice). For the
comparison of spontaneous seizures frequency between strains,
WT (eight mice) and TgS (12 mice) were simultaneously video-
monitored 1 month following SE.
PROCESSING OF TISSUE SAMPLES
Forty-eight hours after SE, animals were deeply anesthetized
with isoﬂuorane and decapitated. For enzymatic activity and
R T - P C R ,b r a i n sw e r eq u i c k l yr e m o v e da n dt h eh i p p o c a m p u s
was dissected and frozen in liquid nitrogen. All tissues were
stored fresh at −80◦C. For native protein extraction, frozen
tissue was thawed and homogenized on ice with 200μl homog-
enization buffer (0.01M sodium phosphate pH 7.4, 1% triton,
4◦C). Lysates were pre-cleared by centrifugation at 17,000rpm
at 4◦C for 30min, and the total protein concentration of
the supernatant was determined using Bradford solution (Bio-
Rad, Israel) (Bradford, 1976). Bovine serum albumin (BSA)
was used as a standard. The supernatants were kept on ice
until the cholinesterase assay was performed within 2h after
homogenization. For histological staining, hemispheres were
either ﬁxed in 4% paraformaldehyde (PFA) in phosphate buffer
saline (PBS) for 48h and parafﬁn-embedded, or horizon-
tally sliced to 400μm sections, ﬁxed in 4% PFA in phos-
phate buffer (PB) (0.1M Na2HPO4, 0.02M NaH2PO4,p H
7.4) and kept in 4◦C until re-slicing. Slices were immersed
in 30% sucrose overnight and then re-sliced to 30μms e c -
tions in a freezing microtome (Leica Microsystems, Wetzlar,
Germany).
KARNOVSKY-ROOT STAINING IN NON-DENATURING
ELECTROPHORESIS GEL AND BRAIN SECTIONS
Electrophoresis ofactive AChE wasperformed innon-denaturing
conditions. Fifty milligrams protein from each supernatant was
loaded on 7.5% vertical polyacrylamide gel at 4◦Cf o r1 h
(Bon et al., 1988). Migration was performed in the presence of
0.25% Triton X-100; AChE activity was revealed as reported by
Karnovsky and Roots (Karnovsky and Roots, 1964; Kaufer et al.,
1998). Bands intensity was quantiﬁed using a homemade MatLab
script.AChEactivitystainingwasperformedin200μmfreshhor-
izontal sections using the same staining solution (Zimmerman
et al., 2008). Images were taken with a stereomicroscope (Zeiss,
Lumar.V12 and an AxiCam MRc5).
REAL-TIME RT-PCR, In-situ HYBRIDIZATION AND IMMUNOSTAINING
Real-time RT-PCR was performed using a standard protocol as
previously described (Zimmerman et al., 2008). Total RNA was
extracted using Absolutely RNA Miniprep Kit (Stratagene, CA,
USA), and reverse transcribed (300ng) using Verso™ cDNA Kit
(Thermo, MA, USA). RT-PCR was performed using ABsolute™
QPCR SYBR® Green ROX (ABgene, UK) in a 7900HT Sequence
Detection System (AppliedBiosystems, CA, USA).Quantiﬁcation
was assessed at the logarithmic phase of the PCR reaction.
T h eP C Ra n n e a l i n gt e m p e r a t u r ew a s6 0 ◦C for all primer pairs
(Table 1).Glyceraldehyde-3-phosphatedehydrogenase(GAPDH)
was used as a house-keeping gene.
For double labeling histological experiments we combined
in-situ hybridization (FISH) with immunoﬂuorescence (IF).
Stainings were done on seven μm-thick parafﬁn-embedded
sagittal sections or 30μm-thick freezing microtome horizon-
tal sections. Prior to staining, 30μm sections were washed
three times in PB and mounted on SuperFrost slides (Thermo,
MA, USA). FISH was performed as previously described
(Berson et al., 2008) with slight modiﬁcations: for antigen
retrieval, slides were soaked in 0.01M citrate buffer pH six,
heated in the micro-wave for 15min, washed in double-
distilled water and with PBT. Hybridization mix [including
50-mer 5 -biotinylated, 2-O-methylprotected complementary
RNA probes (Table 2)1 0 μg/ml] was applied for 10min in
60◦C and then for 90min in 52◦C (90min and overnight
respectively for 30μm sections). After washing with TBST
buffer (25mM Tris–HCl pH 7.5, 136mM NaCl, 2.7mM KCl,
0.05% Tween-20), slides were incubated in blocking solu-
tion for 30min. Primary antibodies (Table 3) diluted in the
blocking solution were incubated (90min) at room temper-
ature (30μm sections—overnight in 4◦C). After three rinses
in TBST, sections were incubated in a mix of streptavidin-
conjugated Cy2 and Cy3 or Cy5 conjugated goat IgG (Jackson
Immunoresearch, 1:100 dilution) in TBST for 1h at room tem-
perature. Slides were then washed with TBST, and mounted with
ImmunoMount (Thermo, MA, USA). Slides stained for Iba1
were incubated in PBS with 0.5% Triton X-100 for 1h, before
blocking.
Frontiers in Molecular Neuroscience www.frontiersin.org M a y2 0 1 2|V o l u m e5|A r t i c l e6 6| 2Gnatek et al. AChE promoting inﬂammation after SE
Table 1 | Primer pairs.
Gene Accession # Primers
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) NM017008 F(1242): GGGTGTGAACCACGAG
R(1417): AGGGGCCATCCACAGTCT
Acetylcholinesterase (AChE)S-variant AF002993 F(7855): CTTCTGGAACCGCTTCCTCCCCAAATT
R(6916): GTAGTGGTCGAACTGGTTCTTCCAGTGCAC
Acetylcholinesterase (AChE)R-variant AF002993 F(7855): CTTCTGGAACCGCTTCCTCCCCAAATT
R(7779): GGTTACACCTGGCGGGCTCC
Acetylcholinesterase (AChE)N-variant AY389979 F(188): AATGCTAGGCCTGGTGATGT
R(285): GGCAGTGGAAACTTCTGGA
Interleukin 1 beta (IL-1β) NM008361.3 F(368): GCCCATCCTCTGTGACTCAT
R(597): AGGCCACAGGTATTTTGTCG
Interleukin 12 (IL-12) M86672.1 F(600): CATCGATGAGCTGATGCAGT
R(762): CAGATAGCCCATCACCCTGT
Tumor necrosis factor alpha(TNF-α) NM013693 F(946): AGCCCCCAGTCTGTATCCTT
R(1157): CTCCCTTTGCAGAACTCAGG
High-mobility group box 1 (HMGB1) NM010439.3 F(4): ACAGAGCGGAGAGAGTGAGG
R(247): GGGTGCTTCTTCTTGTGCTC
Table 2 | Complementary RNA probes.
Probe Beginning point in the mouse AChE gene Sequence
mAChE-S Exon E6 position 1,392 5 -CCCCUAGUGGGAGGAAGUCGGGGAGGAGUGGACAGGGCCUGGGGGCUCGG-3 
mAChE-R Intron I4 position 74 5 -AACCCUUGCCGCCUUGUGCAUUCCCUGCUCCCCCCACUCCAUGCGCCUAC-3 
Table 3 | Dilution, blocking, and designated sections for all primary antibodies.
Primary antibody Source Dilution Blocking Designated sections
Mouse anti-GFAP Sigma 1:400 4% goat serum (Sigma) + 7μm-thick parafﬁn-
Rabbit anti-GAD65/67 Sigma 1:400 2% BSA (Sigma) embedded sections
Mouse anti-NeuN Chemicon 1:100 30μm-thick freezing
Rabbit anti-Iba1 Wako 1:1000 (+0.3% Dyna Antibody Diluant microtome sections
Triton X-100) (Dyna Scientiﬁc)
(+0.5% Triton X-100)
Abbreviations: GFAP , glial ﬁbrillary acidic protein; GAD, glutamic acid decarboxylase; NeuN, neuronal nuclei; Iba1, ionized calcium binding adaptor molecule 1.
ACUTE SLICES PREPARATION AND DRUG APPLICATION
Preparation and maintenance of brain slices ex-vivo was per-
f o r m e du s i n gs t a n d a r dp r o c e d u r e sa sp r e v i o u s l yr e p o r t e d
(Zimmerman et al., 2008). In short, mice (2–4 month old)
were deeply anesthetized; brains quickly removed and 400μm
horizontal slices were obtained (NVSLM1—motorized advance
vibroslice, WPI, USA). Slices were maintained in a standard
interface chamber at 36 ± 1◦C and were superfused with artiﬁ-
cial cerebrospinal ﬂuid (ACSF) contained (in mM): NaCl, 129;
NaHCO3, 21; NaH2PO4, 1.25; MgSO4, 1.8; CaCl2, 1.6; KCl, 3;
glucose, 10; pH 7.4. Treated slices were incubated simultaneously
with matched controls (in separate chambers). Drugs were added
to the bathing solution after 30min incubation with ACSF for
4h. Slices were then transferred to liquid nitrogen for RT-PCR.
Drugs included carbamylcholine chloride (CCh, 50μM), acetyl-
choline (ACh 10 or 50μM), physostigmine (1μM), Atropine
(1μM), Mecamylamine (50μM), α-bungarotoxin (100μM) and
tetrodotoxine (TTX, 1μM).
MICROSCOPY AND IMAGE ACQUISITION
All ﬂuorescent images were obtained using XYZ scanning with
an Olympus FluoView FV1000 confocal microscope (Olympus,
Hamburg, Germany) or with a Nikon inverted TI microscope
(Nikon, Japan) and a cooled 14 bit CCD camera (Coolsnap HQ2,
Photometrics, TucsonAZ). Forquantiﬁcation,Sixto eightimages
(×20) from non-overlappinghippocampalﬁelds were takenfrom
each slice (three slices per animal, two to three animals per group)
using the same acquisition parameters. Analysis was done using a
homemade MatLab script: intensity values for each image were
normalized to the mean. A constant cut-off value was set to
establish a threshold deﬁning background (“black”) and signal
(“white”) pixels. The total number of white pixels (stained area)
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for each binary image was summed and that value was later used
for statistical analysis.
STATISTICAL ANALYSIS
The non-parametric Mann–Whitney test, One-Way ANOVA,
Chi-square (χ2), and two-tailed independent student t-test were
applied (SPSS; SPSS Inc., Chicago, USA) as mentioned in the
text. P < 0.05 was considered signiﬁcant. Data is expressed as the
mean ± SEM.
RESULTS
SE was achieved in 75.7% of mice injected with pilocarpine (n =
53 out of 70) with a mortality rate of 22.6%. In WT mice, 48h
video-monitoring at 3 months after SE revealed a high percent-
age (n = 9 out of 11, 82%) of epileptic mice (≥1s p o n t a n e o u s
unprovoked stage 5 seizure).
AChE IS UP-REGULATED DURING EPILEPTOGENESIS
As previousstudies showed AChE upregulationinchronic epilep-
tic animals,we studied AChE expression 48h after SEto challenge
the hypothesis that cholinergic imbalance occurs early during
the epileptogenesis process. All known alternatively spliced AChE
mRNA transcripts, including AChE-S, AChE-R, and N-AChE
were found to be signiﬁcantly up-regulated in the hippocampus
of treated mice compared to saline-injected controls (Figure1A).
Karnovsky–Root staining conﬁrmed increased AChE activity in
hippocampal homogenates (Figure1B) as well as in sections
obtained from SE-experienced mice (Figure1C). Within the
hippocampus, AChE activity was most prominent in the stra-
tum molecular of the dentate gyrus, the stratum oriens of the
CA1 and CA3 regions, the subiculum and the entorhinal cortex
(Figure1C).
To identify speciﬁc cell populations expressing AChE mRNA
following SE, we combined AChE FISH with immunostain-
ing against speciﬁc cell-type markers. FISH showed intensiﬁed
AChE expression in neurons within all regions of the hip-
pocampus, which was most prominent in the pyramidal cell
layer of all CA sub-regions (Figures2A,B,G). In addition,
ACHE mRNA was co-localized with GAD positive inhibitory
interneurons in all hippocampal sub-regions (Figure2H). We
further searched for AChE expression in glia cells, known
to be activated early following SE and suggested to play
a role in epileptogenesis (Borges et al., 2003; Turrin and
Rivest, 2004; Ivens et al., 2007; Pitkanen et al., 2007; David
et al., 2009). GFAP immunostaning indeed indicated a strong
astroglial activation after SE (Figures2C,D); However, while
AChE mRNA was observed along blood vessels, probably in
endothelial cells, co-labeling experiments failed to reveal sig-
niﬁcant ACHE mRNA expression within GFAP-positive astro-
cytes (Figures2I,J). Conversely, in SE-exposed mice we found
a robust increase in immunolabeling for the microglia marker,
Iba1 (Figures2E,F; p < 0.001; control: n = 47, treated: n = 70
ﬁelds fromthree sections peranimal,2/3animalspergroup;inde-
pendent t-test), co-labeled with a strong FISH signal for AChE
mRNA (Figures2K,L). In addition, Iba1 positive cells follow-
ing SE presented perikaryal hypertrophy and processes retraction
(Figure2L), a clear morphological pattern for their activation
(Rappold et al., 2006).
BRAIN AChE LEVELS AND LOCAL IMMUNE RESPONSE
The rapid up-regulation and expression pattern of AChE after SE
together with the known cholinergic control of immune response
in the periphery led us to challenge the hypothesis that the
observed cholinergic imbalance is sufﬁcient to induce a local
innate immune response within the brain. We thus tested the
immune response in transgenic mice with a constitutive over-
expression of the human synaptic variant of acetylcholinesterase
(AChE-S) (TgS)before and 48h following SE.In TgS mice, show-
ing 50% more AChE activity than WT animals (Beeri et al., 1995;
and Figure3A), immunolabeling against Iba1 was signiﬁcantly
FIGURE 1 | AChE up-regulation 48h post SE. (A) expression levels of
AChE-S, AChE-R, and N-AChE 48h after SE, as revealed by real-time RT-PCR
(p = 0.05, 0.053, and 0.025 respectively; n = 5 controls, n = 3 or 4 treated;
mean ± SEM; Mann–Whitney test). (B) Top: Karnovsky–Roots staining on
non-denatured activity gel of control and 48h after SE samples. Bottom: gel
quantiﬁcation (p = 0.05; n = 3; mean ± SEM; Mann–Whitney test).
(C) Karnovsky–Roots staining of 200μm horizontal brain sections from
control and 48h post SE mice. C, control; T, treated.
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FIGURE 2 | AChE expression in the hippocampus. (A,B) FISH for AChE-R
in the hippocampus of control (A) and 48h after SE (B) mice. (C,D) GFAP
staining in the hippocampus of control (C) and 48h post SE (D) mice.
(E,F) Iba1 staining in the hippocampus of control (E) and 48h post SE (F)
mice. (G) Double labeling of AChE (green) and NeuN (red) in CA1 area of a
treated animal. (H) Double labeling of AChE (green) and GAD65/67 (red) in
the hilus of a treated animal. (I,J) Double labeling of AChE (green) and GFAP
(red) in hippocampus of control (I) and treated (J) mice (scale 10μm). Note
the clear positive AChE staining in the blood vessel and the endothelial cells
but not in the end ﬁt of GFAP-positive astrocytes surrounding it. (K,L) Double
labeling of AChE (green) and Iba1 (red) in hippocampus of control (K) and
treated (L) mice (scale 10μm).
increased compared to WT (p = 0.046; WT: n = 47, TgS: n = 70
ﬁelds from three sections per animal, 2/3 animals per group;
independent t-test). This increase was associated with upregu-
lation of mRNA for high mobility group box 1 (HMGB1)—a
pro-inﬂammatory cytokine-like mediator expressed in activated
microglia (Lotze and Tracey, 2005; Kim et al., 2006; Hayakawa
et al., 2008)( Figure3F; p = 0.014). Forty-eight hours following
SE both WT and TgS mice showed higher labeling of Iba1 com-
pared to their matched controls (Figure3B); However, treated
TgSmiceshowed signiﬁcantlyhigher (30%)labelingcomparedto
that observed in treated WTs (17%) (p = 0.043; control: n = 47,
treated: n = 71 ﬁelds from three sections per animal, 2/3 ani-
mals per group; independent t-test). In addition, up-regulation
of IL-1β and IL-12 was signiﬁcantly higher in TgS mice com-
pared to WT (Figures3C,D). SE-induced up-regulation of TNFα
mRNA was similar in both WT and TgS mice (Figure3E).
HMGB1 was also upregulated (p = 0.027) in WT exposed to
SE and matched the already high levels in non-treated TgS
(Figure3F).
TgS MICE OVER-EXPRESSING AChE SHOW ACCELERATED
EPILEPTOGENESIS
To test whether the observed increase in immune response
in treated TgS mice is associated with altered epileptogenesis
(Vezzani et al., 2008), we video-monitored WT and TgS mice
for 48h one month after SE. Importantly, no differences in the
acute response to pilocarpine (rate of SE, delay to SE, seizure
phenotypes, response to diazepam or survival) were observed
between WT and TgS mice (Figures4A–C). In contrast, video-
monitoring at 1 month uncovered a signiﬁcantly higher rate of
TgS mice presenting spontaneous seizures compared to WT mice
(Figure4D). These results support the notion that AChE over-
expression is associated with enhanced immune response and
facilitated epileptogenesis.
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FIGURE 3 | Compared microglia status in WT and TgS mice.
(A) Karnovsky–Roots staining of 200μm horizontal brain sections from
naïve WT and TgS mice. (B) Iba1 staining in the hippocampus of
control WT (B1), control TgS (B2), treated WT (B3), and treated TgS (B4)
mice. (C–F) Real-time RT-PCR for key inﬂammatory cytokines. (C) IL -1β
mRNA relative levels (∗p = 0.014; ∗∗p = 0.004). (D) IL-12 mRNA
relative levels (∗p = 0.014; ∗∗p = 0.004). (E) TNFα mRNA relative levels.
WT: p = 0.027 , TgS: p = 0.054. (F) HMGB1 mRNA relative levels.
p < 0.05 (see text). (WT: n = 5 controls, n = 4 treated, TgS: n = 6
controls/treated. In F; TgS control: n = 4; C, control; T, treated; Statistical
analysis was done using the non-parametric Mann–Whitney test, mean ±
SEM.)
CHOLINERGIC ACTIVATION IS ANTI-INFLAMMATORY IN
HIPPOCAMPAL SLICES
Our results suggested that the rapid up-regulation of AChE fol-
lowing SE is associated with enhanced local immune response.
To explore to what extent this effect is associated with reduced
cholinergic control over the brain innate immune response, we
studied the immune response in acute brain slices maintained ex-
vitro4hfollowingtheslicingprocedure.Wehypothesized thatthe
injury associated with the slicing procedure would activate a sig-
niﬁcant inﬂammatory response (Lucas et al., 2006) which could
be suppressed by cholinergic stimuli. Indeed, cholinergic activa-
tion by 50μM CCh reduced mRNA levels of IL1β and TNFα
(Figure5A). Similar results were found with low levels of the
physiological agonist, ACh (10μM), in the presence of the AChE
inhibitor physostigmine (1μM,Figure5A). The addition of TTX
did not prevent CCh action on the immune response, suggesting
it is not dependent on neuronal ﬁring (Figure5B). Importantly,
while the non-speciﬁc muscarinic receptor antagonist atropine
blocked the cholinergic-suppression of inﬂammatory response,
the non-speciﬁc nicotinic receptor antagonist, mecamylamine
(50μM) or the α7 nicotinic receptor antagonist α-bungarotoxin
(100nM) did not (Figure5B and data not shown).
DISCUSSION
In this study we offer experimental evidence indicating that (1)
cholinergic imbalance due to upregulation of AChE within the
hippocampus is associated with a local immune response; (2)
such imbalance and the associated inﬂammation following SE is
associated with epileptogenesis; and (3) ACh acts directly as a
modulator of brain innate immune response and thereby affect
epileptogenesis.
AChE is the fastest enzyme in mammalian cells and as the
enzyme in charge of executing ACh breakdown it is a key compo-
nent of cholinergic signaling (Meshorer and Soreq, 2006). AChE
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FIGURE 4 | SE and spontaneous seizures in TgS and WT mice. (A) Time
(in min) was measured from pilocarpine injection to onset of SE.
(B) Percentage of mice achieving SE. (C) Percentage of mice surviving
40min of SE (total number of injected animals: WT: n = 33, TgS: n = 44).
(D) Percentage of mice presenting spontaneous seizures 1 month after SE
(∗p = 0.019, Chi-square test; number of monitored animals: WT: n = 8,
TgS: n = 12).
levels are controlled via transcriptional and post-transcriptional
mechanisms and are dramatically increased under toxicological,
physical and psychological stress (Kaufer et al., 1998; Shohami
et al.,2000; Meshoreret al.,2002).Thisfastandrobustincreasein
AChE levelsinresponse to neuronalactivation hasbeensuggested
to act as an homeostatic control to reduce neuronal excitabil-
ity (Meshorer et al., 2005b) and on the long-run this response
was reported to be associated with enhanced network excitability
(Meshorer et al., 2002; Zimmerman et al., 2008). These previ-
ous ﬁndings raised the hypothesis that AChE will be similarly
up-regulated following SE in the pilocarpine model of epilepsy.
Indeed, 48h following SE we recorded increased AChE mRNA
and protein levels in SE-experienced mice. Unlike milder and
more speciﬁc stress manipulations (e.g., psychological) where
upregulation was reported to include the readthrough alterna-
tively spliced AChE-Rvariant (Kaufer et al., 1998; Meshorer et al.,
2002), SE wasassociated with a signiﬁcant increase in mRNA lev-
els of all three alternatively spliced transcripts (Figure1). In this
study we used the muscarinic agonist, pilocarpine, to induce SE
andthusitispossiblethatAChEupregulationrepresentsaspeciﬁc
response to the activation of muscarinic receptors. While we can-
not entirely exclude this possibility, it seems unlikely in light of a
similar up-regulation observed in the brains from chronic epilep-
tic rats following kainic acid-induced SE (Zimmerman et al.,
2008). The presence of c-fos binding sites in the promoter of
t h eg e n ee n c o d i n gA C h E( Meshorer et al., 2004) further sug-
gest that its upregulation is part of the transcriptional response
to excess neuronal activation. AChE transcripts were found in
both principle and inhibitory interneurons, supporting its role
in controlling the hyperexcitable network. In addition, follow-
ing SE high expression levels of AChE mRNA were also found
in morphologically identiﬁed endothelial cells, suggesting it may
have a role in vascular changes observed following SE, speciﬁcally
the robust increase in blood-brain barrier (BBB) permeability
(van Vliet et al., 2007; Weissberg et al., 2011). This notion is
supported by reports on compromised BBB in transgenic mice
over-expressing AChE (Meshorer et al., 2005a). The activation
of the immune system, and speciﬁcally HMGB1 upregulation in
these transgenic animals (Figure3) may also underlie BBB open-
ing (Zhang et al., 2011). AChE transcripts were not found in
GFAP positive astrocytes, despite their robust activation during
SE. These results are consistent with a previous report showing
AChE activity in different lines of neuronal and non-neuronal
cells except for astrocytes (Thullberyet al., 2005), although mixed
astroglia cells werereported to upregulatethe readthrough ACHE
transcript following oxidative stress in culture (Bond et al., 2006).
High expression levels of ACHE transcripts were found in Iba1
positive microglia following SE and to much less extent in con-
trol animals. These results together with the well-described brain
immune activation following SE (review by Vezzani et al., 2011)
raised the hypothesis that AChE upregulation in microglia may
have a role in modulating the innate immune response. This
hypothesis is supported by previous studies showing that in
microglial cell cultures AChE induces changes in cell morphol-
ogy as well as iNOS upregulation (von Bernhardi et al., 2003).
That the AChE effect is likely to be associated with choliner-
gic signaling is suggested by the observation that ACh inhibits
LPS-induced TNFα release in microglia cultures, an effect atten-
uated by α-bungarotoxin (Shytle et al., 2004). To test directly the
role of AChE overexpression on microglia functions we studied
transgenic mice with CNS limited, constitutive up-regulation of
synaptic AChE-S (Sternfeld et al., 2000). Indeed, the increase in
AChE activity led to increased immunostaining of the microglial
marker Iba1 and signiﬁcant upregulation of mRNA levels for
HMGB1(Figure3),anewlydeﬁnedcytokinethatcanbepassively
released from necrotic cells or actively released from immune
activated cells (Wang et al., 1999; Abraham et al., 2000). Our
ﬁnding showing that AChE over expression in transgenic ani-
mals facilitated epileptogenesis are consistent with recent reports
showing a proconvulsant effect of HMGB1 in kainic acid treated
mice (Maroso et al., 2010). It is worth noticing that TgS mice
showed a robust increase in IL-1β expression (18-fold higher
than WT mice) 48h following SE, consistent with the well-
described epileptogenic effects of IL-1β (Vezzani et al., 1999;
Friedman and Dingledine, 2011). Facilitated epileptogenesis in
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FIGURE 5 | Real-time RT-PCR for IL-1β and TNF-α in acute slices.
(A) mRNA relative levels in slices treated with aCSF , 50μM CCh (∗p = 0.025;
n = 6) or 1μM physostigmine with 10μMA C h( ∗∗p = 0.006; n = 5–6).
(B) mRNA relative levels in slices treated with 50μM CCh (n = 5) and 50μM
CCh with 1μM atropine (∗p = 0.028; n = 5), 100nM BTX (n = 5) or 1μM TTX
(∗p = 0.027; n = 4). Statistical analysis was done using the non-parametric
Mann–Whitney test, mean ± SEM. Physo, physostigmine; BTX,
bungarotoxine.
TgS mice couldnot be solely attributed to enhanced seizure activ-
ity due to increased network sensitivity to ACh (Meshorer et al.,
2002) since the latency and duration of SE in response to pilo-
carpine were similar in WT mice. This strengthens the notion
that AChE upregulation following SE is a response to excess neu-
ronal activation rather than a direct effect of pilocarpine. We
cannot rule out at this stage the contribution of other epilep-
togenic mechanisms including vascular changes (i.e., enhanced
BBB permeability) (Marchi et al., 2007; Friedman et al., 2009)
or changes in peripheral immune response (Fabene et al., 2008;
Marchi et al., 2009). When monitoring WTs for 1–3 month, 82%
showed spontaneous seizures, while TgS were not monitored at
such a late time point. Therefore, it is feasible that the rate of
epileptogenesis and not the end result are different between the
strains.
The most direct evidence for cholinergic control over the
innate immune response is given in the acute slices experiments
demonstrating that adding ACh or CCh to the bathing solution
suppressed mRNA levels of IL-1β and TNF-α. In accordance with
these results, previous studies demonstrated anti-inﬂammatory
effect for ACh and AChE inhibitors in glial cultures (Shytle et al.,
2004; Wang et al., 2010) and for AChE inhibitors in animals
(Nizri et al., 2008; Wang et al., 2008, 2010). It is important to
note that exposure to centrally acting potent AChE inhibitors
induces SE and neuroinﬂammation that may promote epilep-
togenesis (Dhote et al., 2007, 2012; De Araujo Furtado et al.,
2010). Thus, it seems clear that AChE inhibition per se,p e r -
haps due to enhanced neuronal excitability is usually associated
with increased brain inﬂammation and the transient increase in
ACh levels are not sufﬁcient to block completely the brain innate
immune processes associated with SE and chronic recurrent
seizures (Pernot et al., 2009). Unlike previous studies (mostly
in the peripheral nervous system) (Tracey, 2002, 2007; Shytle
et al., 2004; Wang et al., 2008), our ﬁndings point to muscarinic
dependant activation as the underlying pathway. Although mus-
carinic receptors in the CNS were shown to control the periph-
eral nicotinic pathway, hinting to complex interactions between
the involved pathways (Pavlov et al., 2006, 2009), these inter-
actions could not explain the observations in the ex-vivo slice
preparation. Since recent studies did show that cytokines act as
pro-convulsants (Vezzani et al., 2011), their upregulation may
also be attributed to a positive feedback enhancement mecha-
nism. However, it is noteworthy that the sodium channel blocker,
TTX had no effect on cholinergic-suppression of cytokine pro-
duction suggesting that this cholinergic effect is independent of
neuronal ﬁring.
In summary, our study suggests for the ﬁrst time, a role
for activity-dependant cholinergic imbalance in brain immune
response, epileptogenesis and seizures and may offer a new basis
for understanding the role of AChE-inhibitors in the treatment
of Alzheimer’s disease and similar neurodegenerative disorders.
Future studies are warranted to delineate the contribution of
cholinergic signaling to brain immune response in neurologi-
cal and neurodegenerative disorders where immune response has
been reported (Amor et al.,2010)aswellasitspot entialasanov el
target in the treatment of uncontrolled brain immune response.
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